PRESS RELEASE published on 07/17/2024 at 23:27, 1 year 4 months ago Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data showing high-sustained factor levels with once-weekly dosing in children with severe hemophilia A, effective bleed protection, and no inhibitor development to factor VIII ALTUVIIIO NEJM XTEND-Kids Hemophilia A Factor VIII
BRIEF published on 06/26/2024 at 23:35, 1 year 5 months ago Dupixent: Positive Data for Children With Eosinophilic Esophagitis Clinical Study Children Dupixent Phase III Eosinophilic Esophagitis
PRESS RELEASE published on 06/26/2024 at 23:30, 1 year 5 months ago Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Positive phase 3 data of Dupixent in children aged 1-11 with eosinophilic esophagitis published in NEJM highlights significant histologic remission achieved and sustained improvements, potentially changing standard of care Children Phase 3 Study Dupixent Eosinophilic Esophagitis NEJM Publication
BRIEF published on 06/25/2024 at 19:37, 1 year 5 months ago Sanofi Releases Q2 2024 Aide-Mémoire to Assist Financial Modelling Financial Results Investors Q2 2024 Sanofi Aide-mémoire
PRESS RELEASE published on 06/25/2024 at 19:32, 1 year 5 months ago Press Release: Availability of the Q2 2024 Aide-mémoire Sanofi announces availability of Q2 2024 Aide-mémoire, assisting in financial modeling of quarterly results. Document includes non-comparable items, exclusivity losses, and more Q2 2024 Quarterly Results Sanofi Financial Modeling Aide-mémoire
BRIEF published on 06/21/2024 at 09:35, 1 year 5 months ago Sanofi appoints Audrey Duval Derveloy Group Corporate Affairs Director Executive Committee Social Responsibility Nomination Sanofi Audrey Duval Derveloy
PRESS RELEASE published on 06/21/2024 at 09:30, 1 year 5 months ago Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
BRIEF published on 06/21/2024 at 07:05, 1 year 5 months ago Sanofi strengthens its leadership in the treatment of hemophilia Sanofi Fitusiran ISTH Haemophilia ALTUVIIO
PRESS RELEASE published on 06/21/2024 at 07:00, 1 year 5 months ago Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025 Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF published on 06/12/2024 at 20:24, 1 year 5 months ago Sanofi: Information on voting rights and shares - May 2024 Voting Rights Investors Actions Sanofi May 2024
Published on 12/05/2025 at 02:35, 7 hours 10 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 45 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 40 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 45 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:30, 15 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 40 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 45 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 1 minute ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health